Pyrimidines and their pharmaceutical acceptable salts, and their

Details Pyrimidines and their pharmaceutical acceptable salts, and their Pyrimidines and their pharmaceutical acceptable salts, and their

1992-05-26

1993-11-23

Tsang, Cecilia

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514258, 544280, A61K 31505, A61K 31495, C07D48700

Patent

active

052644359

ABSTRACT:
2,6-di-, 2,4,6-, 2,5,6-tri- or 2,4,5,6-tetra-substituted pyrimidines, and 2,6-di-substituted pyridines. These compounds are useful for treatment of neurological deseases.

REFERENCES:
patent: 3714165 (1973-01-01), Beaulour et al.
patent: 3775412 (1973-11-01), Kim et al.
patent: 3984414 (1976-10-01), Esanu
patent: 4073895 (1978-02-01), Esanu
patent: 4226995 (1980-10-01), Demosthene et al.
patent: 4266058 (1981-05-01), Demosthene et al.
patent: 4267181 (1981-05-01), Esanu
patent: 4297495 (1981-10-01), Esanu
patent: 4344947 (1982-08-01), Huve
patent: 4416885 (1983-11-01), Huve
patent: 4742165 (1988-05-01), Yohoyama et al.
patent: 4959368 (1990-09-01), Awaya et al.
Patent Abstracts of Japan, vol. 11, No. 282 (C-446) (2729), 11 Sep. 1987, JP-A-62 81 375 (Teikoku Chem. Ind. Corp. Ltd.), 14 Apr. 1987.
The Jouranl of Chemica Society, 1965, 755-761.
La nouvelle Presse Medicale, vol. 16, 1189-1280.

Affiliated with

Also associated with

Rating

Pyrimidines and their pharmaceutical acceptable salts, and their does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidines and their pharmaceutical acceptable salts, and their, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidines and their pharmaceutical acceptable salts, and their will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1849065